Evaluation changes in indicators of oncological service in breast cancer in Kazakhstan

N. Igissinov, Asem Toguzbayeva, G. Igissinova, Z. Bilyalova
{"title":"Evaluation changes in indicators of oncological service in breast cancer in Kazakhstan","authors":"N. Igissinov, Asem Toguzbayeva, G. Igissinova, Z. Bilyalova","doi":"10.31082/1728-452x-2020-211-212-1-2-16-20","DOIUrl":null,"url":null,"abstract":"According to estimates from the International Agency for Research on Cancer (IARC) by 2040 the global burden is expected to grow to 3 million new breast cancer cases and 1 million cancer deaths of this cause. Studying the indicators of the oncological service for breast cancer allows us to identify and evaluate the effectiveness of mammological screening in Kazakhstan. Aim. Evaluate some indicators of the oncological service at breast cancer in Kazakhstan in 2009 to 2018. Material and methods. The research material was data from the Ministry of Health of the Republic of Kazakhstan - annual form No.7 and No.35 regarding breast cancer (ICD 10 C50) for 2009-2018. - morbidity, mortality, early diagnosis, neglect, morphological verification. A retrospective study using descriptive and analytical methods of biomedical statistics was used as the main method. Results and discussion. For 2009-2018, 40,199 new cases of breast cancer were registered in the republic for the first time and 12,971 women died from this disease. The average annual crude incidence rate of breast cancer was 45.4±1.40/0000 (95% CI=42.8-48.1) and increased in dynamics from 39.5±0.70/0000 (2009) to 49.6±0.70/0000 in 2018, the difference was statistically significant (t=10.2 and p=0.000). In dynamics, mortality rates from breast cancer tended to statistically significant (t=7.95 and p=0.000) decrease from 16.5±0.40/0000 (2009) to 12.0±0.40/0000 in 2018 year, and the average annual crude mortality rate from breast cancer was 14.8 0.50/0000 (95% CI=13.7-15.8). The indicators of early diagnosis (the proportion of patients with stage I-II) improved from 71.1% (2009) to 87.6% in 2018, the proportion of patients with stage III decreased (from 22.2% to 8.6 %) and stage IV (from 6.4% to 3.6%) for the studied years, i.e. neglect rates are declining. The indicators of morphological verification in breast cancer have always been high and over the studied years improved from 93.4% to 99.1%. Conclusion. An analysis of the indicators of the oncological service at breast cancer revealed an improvement in morphological verification and early diagnosis, a decrease in neglect and mortality rates, which is undoubtedly associated with ongoing anti-cancer measures in Kazakhstan, which a regularly mammological screening. Keywords: breast cancer, incidence, mortality, early diagnosis, neglect, morphological neglect.","PeriodicalId":14842,"journal":{"name":"Journal \"Medicine\"","volume":"39 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2020-04-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal \"Medicine\"","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.31082/1728-452x-2020-211-212-1-2-16-20","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

According to estimates from the International Agency for Research on Cancer (IARC) by 2040 the global burden is expected to grow to 3 million new breast cancer cases and 1 million cancer deaths of this cause. Studying the indicators of the oncological service for breast cancer allows us to identify and evaluate the effectiveness of mammological screening in Kazakhstan. Aim. Evaluate some indicators of the oncological service at breast cancer in Kazakhstan in 2009 to 2018. Material and methods. The research material was data from the Ministry of Health of the Republic of Kazakhstan - annual form No.7 and No.35 regarding breast cancer (ICD 10 C50) for 2009-2018. - morbidity, mortality, early diagnosis, neglect, morphological verification. A retrospective study using descriptive and analytical methods of biomedical statistics was used as the main method. Results and discussion. For 2009-2018, 40,199 new cases of breast cancer were registered in the republic for the first time and 12,971 women died from this disease. The average annual crude incidence rate of breast cancer was 45.4±1.40/0000 (95% CI=42.8-48.1) and increased in dynamics from 39.5±0.70/0000 (2009) to 49.6±0.70/0000 in 2018, the difference was statistically significant (t=10.2 and p=0.000). In dynamics, mortality rates from breast cancer tended to statistically significant (t=7.95 and p=0.000) decrease from 16.5±0.40/0000 (2009) to 12.0±0.40/0000 in 2018 year, and the average annual crude mortality rate from breast cancer was 14.8 0.50/0000 (95% CI=13.7-15.8). The indicators of early diagnosis (the proportion of patients with stage I-II) improved from 71.1% (2009) to 87.6% in 2018, the proportion of patients with stage III decreased (from 22.2% to 8.6 %) and stage IV (from 6.4% to 3.6%) for the studied years, i.e. neglect rates are declining. The indicators of morphological verification in breast cancer have always been high and over the studied years improved from 93.4% to 99.1%. Conclusion. An analysis of the indicators of the oncological service at breast cancer revealed an improvement in morphological verification and early diagnosis, a decrease in neglect and mortality rates, which is undoubtedly associated with ongoing anti-cancer measures in Kazakhstan, which a regularly mammological screening. Keywords: breast cancer, incidence, mortality, early diagnosis, neglect, morphological neglect.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
哈萨克斯坦乳腺癌肿瘤服务指标的评价变化
根据国际癌症研究机构(IARC)的估计,到2040年,全球负担预计将增加到300万新的乳腺癌病例和100万癌症死亡病例。研究乳腺癌肿瘤服务的指标使我们能够确定和评估哈萨克斯坦乳腺筛查的有效性。的目标。对哈萨克斯坦2009 - 2018年乳腺癌肿瘤服务的部分指标进行评价。材料和方法。研究材料是来自哈萨克斯坦共和国卫生部的数据——2009-2018年关于乳腺癌的年度表格No.7和No.35 (ICD 10c50)。-发病率,死亡率,早期诊断,忽视,形态学验证。采用生物医学统计学的描述性和分析性方法进行回顾性研究。结果和讨论。2009-2018年,共和国首次登记了40199例乳腺癌新病例,12971名妇女死于这种疾病。乳腺癌年平均粗发病率为45.4±1.40/0000 (95% CI=42.8 ~ 48.1),从2009年的39.5±0.70/0000上升至2018年的49.6±0.70/0000,差异有统计学意义(t=10.2, p=0.000)。动态方面,乳腺癌死亡率从2009年的16.5±0.40/0000下降到2018年的12.0±0.40/0000,有统计学意义(t=7.95, p=0.000),乳腺癌年平均粗死亡率为14.8 0.50/0000 (95% CI=13.7 ~ 15.8)。早期诊断指标(I-II期患者占比)从2009年的71.1%提高到2018年的87.6%,III期患者占比从22.2%下降到8.6%,IV期患者占比从6.4%下降到3.6%,即忽视率在下降。乳腺癌的形态学验证指标一直很高,多年来从93.4%提高到99.1%。结论。对乳腺癌肿瘤学服务指标的分析表明,形态学核查和早期诊断有所改善,忽视率和死亡率有所下降,这无疑与哈萨克斯坦正在采取的抗癌措施有关,其中定期进行乳腺检查。关键词:乳腺癌,发病率,死亡率,早期诊断,忽视,形态学忽视。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
The conception of the probable role of the biological active chromium in the emergence of insulin resistance and alimentary obesity Frequency of symptoms of temporominal joint dysfunction in children and adolescents in orphanages Human teeth enamel as a test for assessing the consequences of radiation pollution of the environment Essential tremor not just a tremor (review) Neurological manifestations of tuberous sclerosis in children (own observations)
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1